In a Phase 2 trial, patients with type 2 diabetes mellitus and nonalcoholic fatty liver disease were randomly assigned to given placebo, 25 or 50 mg OCA for 6 weeks, it shows increased insulin sensitivity (by 28.0% from baseline with 25 mg OCA (P=0.019) and 20.1% from baseline with 50 mg OCA (P=0.060)), and decreased biological indicators of liver inflammation and fibrosis (NCT00501592)
Long-term management involves regular monitoring appointments to assess treatment efficacy, side effects, and the need for dose adjustments
Aim for minimum caloric floors based on your goals, typically no lower than 1,200 to 1,500 calories daily for men, even if appetite would allow less
Oxidation resistance 1 is a novel senolytic target
Distribution Through Endocrine Pathways Following administration, both peptides act primarily at the pituitary level, with effects propagated downstream through the GH/IGF-1 axis
Mattioli S, Dimauro C, Cesarani A, Dal Bosco A, Bartolini D, Galli F et al (2022) A dynamic model for estimating the interaction of ROSPUFAantioxidants in rabbit